Cargando…
Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against Streptococcus pneumoniae Infections in Mice
Infectious diseases are the second leading cause of death worldwide, highlighting the importance of the development of a novel and improved strategy for fighting pathogenic microbes. Streptococcus pneumoniae is a highly pathogenic bacteria that causes pneumonia with high mortality rates, especially...
Autores principales: | Tada, Rui, Suzuki, Hidehiko, Ogasawara, Miki, Yamanaka, Daisuke, Adachi, Yoshiyuki, Kunisawa, Jun, Negishi, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073337/ https://www.ncbi.nlm.nih.gov/pubmed/33923897 http://dx.doi.org/10.3390/pharmaceutics13040585 |
Ejemplares similares
-
Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice
por: Tada, Rui, et al.
Publicado: (2021) -
Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus
pneumoniae-Specific IgA and Th17 Mediated Protective Immunity
por: Yoshii, Ken, et al.
Publicado: (2020) -
Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes
por: Tada, Rui, et al.
Publicado: (2021) -
C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine
por: Suzuki, Hidehiko, et al.
Publicado: (2015) -
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
por: Tada, Rui, et al.
Publicado: (2017)